tirzepatide biosimilar In the News... New research in T1D prevention, fast-acting insulin approved, Lilly lowers Zepbound price, and more! Tirzepatide TFA (LY3298176 TFA, GIP

Effects of Tirzepatide on weight loss and cardiometabolic health

Molecular identity requires suitable supporting analysis

During pathological conditions like diabetes, COPD, and kidney disease, structural modifications of HSA induced by glucose or acrolein can strongly impair its antioxidant properties

The FDA will ultimately make the final regulatory decision through a formal rulemaking process, and the agency has gone against advisory panel recommendations before

If you have Type 2 diabetes, your provider can prescribe Ozempic (semaglutide for diabetes), which is covered by most provincial health plans and private insurance with restrictions

This was achieved by excluding one study at a time and observing the changes in the pooled HRs